NRF2驱动GSTA4转录调控控制特应性皮炎复发中的慢性炎症与氧化应激
本研究从临床结局回溯机制,建立小鼠复发型特应性皮炎模型并应用临床验证方案,通过转录组分析发现谷胱甘肽代谢通路富集,鉴定GSTA4为复发关键介质;患者皮损中GSTA4表达降低,过表达GSTA4可减轻AD样炎症与ROS,NRF2调控GSTA4转录,治疗增强该轴产生抗炎抗氧化效应。
要点
- GSTA4在AD复发中起关键介导作用,患者皮损GSTA4表达降低。
- 过表达GSTA4可显著减轻AD样炎症反应与ROS产生。
- NRF2转录活性调控GSTA4,治疗增强NRF2-GSTA4轴发挥抗炎抗氧化作用。
核心结论
- GSTA4是AD复发中的关键因子,尤其在氧化应激与慢性炎症背景下。
- 靶向NRF2-GSTA4轴是预防AD复发的潜在抗炎抗氧化策略。
研究设计与样本
- 研究采用从临床结局回溯复发机制的策略,建立小鼠复发型AD模型并应用临床验证治疗方案。
- 结合转录组分析、生物信息学整合与体内验证,并在AD患者皮损中进行免疫组化分析。
主要发现
- 转录组分析显示治疗组谷胱甘肽代谢通路显著富集。
- 整合生物信息学与体内验证鉴定GSTA4为AD复发的关键介质。
- 免疫组化显示AD患者皮损中GSTA4表达降低。
- 体外过表达GSTA4显著减少AD样炎症反应与ROS产生。
- NRF2转录活性调控GSTA4表达与功能,治疗增强NRF2介导的GSTA4转录并产生抗炎与ROS中和效应。
临床怎么用
- NRF2-GSTA4轴可作为预防AD复发的潜在抗炎抗氧化干预靶点。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Atopic dermatitis (AD), a chronic and recurrent inflammatory skin disorder, presents a high incidence and imposes a substantial economic burden. Preventing its recurrence remains a significant challenge in dermatological therapy owing to poorly understood underlying mechanisms. In our study, we adopted a strategy of tracing the mechanisms of recurrence from clinical outcomes. We developed a mouse model of recurrent AD and applied clinically validated treatment regimens. Transcriptomic analyses revealed a pronounced enrichment in the glutathione metabolic pathway in the treated group. Through integrated bioinformatics and in vivo validation, we identified glutathione S-transferase alpha 4 (GSTA4) as a pivotal mediator in AD recurrence. Immunohistochemical analysis demonstrated decreased GSTA4 expression in lesions from patients with AD. Functionally, in vitro overexpression of GSTA4 significantly curtailed AD-like inflammatory responses and ROS production. Moreover, we discovered that NRF2 transcriptional activity regulates GSTA4 expression and function. Our treatment notably augmented NRF2-mediated GSTA4 transcription, yielding pronounced anti-inflammatory and ROS-neutralizing effects. Conclusively, our findings implicate GSTA4 as a critical factor in the recurrence of AD, particularly in the context of oxidative stress and chronic inflammation. Targeting the NRF2-GSTA4 axis emerges as a promising anti-inflammatory and antioxidative strategy for preventing AD recurrence.
引用
- Ma X, Zhao H, Song JK, et al. Retracing from Outcomes to Causes: NRF2-Driven GSTA4 Transcriptional Regulation Controls Chronic Inflammation and Oxidative Stress in Atopic Dermatitis Recurrence. J Invest Dermatol. 2024. PMID: 38879155. doi:10.1016/j.jid.2024.05.018
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。